0.6949
Precedente Chiudi:
$0.6438
Aprire:
$0.67
Volume 24 ore:
985.56K
Relative Volume:
4.01
Capitalizzazione di mercato:
$72.26M
Reddito:
$1.29M
Utile/perdita netta:
$-29.87M
Rapporto P/E:
-1.9303
EPS:
-0.36
Flusso di cassa netto:
$-14.70M
1 W Prestazione:
+8.24%
1M Prestazione:
+7.57%
6M Prestazione:
+10.30%
1 anno Prestazione:
+21.91%
VolitionRX Ltd Stock (VNRX) Company Profile
Nome
VolitionRX Ltd
Settore
Industria
Telefono
646 650 1351
Indirizzo
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Confronta VNRX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
VNRX
VolitionRX Ltd
|
0.6949 | 68.16M | 1.29M | -29.87M | -14.70M | -0.36 |
![]()
TMO
Thermo Fisher Scientific Inc
|
489.01 | 183.16B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
210.93 | 150.53B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
650.84 | 52.32B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
119.20 | 33.77B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
191.09 | 32.20B | 15.50B | 1.33B | 2.16B | 7.34 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-04-08 | Iniziato | H.C. Wainwright | Buy |
2023-02-01 | Downgrade | The Benchmark Company | Buy → Hold |
2022-02-17 | Ripresa | Cantor Fitzgerald | Overweight |
2021-03-10 | Iniziato | Cantor Fitzgerald | Overweight |
2018-05-16 | Iniziato | Maxim Group | Buy |
2018-05-14 | Reiterato | The Benchmark Company | Buy |
2016-09-07 | Reiterato | Rodman & Renshaw | Buy |
2016-02-01 | Iniziato | Rodman & Renshaw | Buy |
Mostra tutto
VolitionRX Ltd Borsa (VNRX) Ultime notizie
VolitionRx Limited stock daily chart insightsQuarterly Profit Review & Real-Time Stock Entry Alerts - Newser
VolitionRx Limited stock outlook for YEAREarnings Beat & Proven Capital Preservation Methods - Newser
Volitionrx Ltd earnings missed by $0.01, revenue fell short of estimates - Investing.com South Africa
VolitionRX Q2 2025 Earnings Call Highlights: Revenue Growth, Strategic Advances, and Cash Challenges - AInvest
VolitionRx Limited (AMEX:VNRX) Q2 2025 Earnings Call Transcript - Insider Monkey
VolitionRX Ltd (VNRX) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Advances ... By GuruFocus - Investing.com Canada
VolitionRX Ltd (VNRX) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Advances ... - Yahoo Finance
VolitionRx Limited stock retracement – recovery analysisMarket Growth Review & Fast Exit and Entry Trade Guides - Newser
Using AI based signals to follow VolitionRx LimitedWeekly Trade Summary & AI Powered Buy and Sell Recommendations - Newser
VolitionRx Reports Q2 2025 Financial Results and Strategic Advancements - AInvest
VolitionRx Reports Q2 2025 Financial Results and Strategic Progress - TipRanks
Earnings call transcript: VolitionRx Q2 2025 sees revenue rise, stock dips - Investing.com
VolitionRX: Q2 Earnings Snapshot - The Wilton Bulletin
VolitionRx : Corporate Presentation August 2025 - MarketScreener
VolitionRX Q2 2025 Earnings Call Transcript - MarketBeat
VolitionRX's Strategic Momentum in Human Diagnostics: Licensing Deals as a Catalyst for Growth - AInvest
VolitionRX Q2 2025 Earnings Preview: Revenue and Earnings Estimates Decline - AInvest
VolitionRX Reports Q2 Earnings with Revenue Growth and Declining Net Loss. - AInvest
VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update - Financial Times
Measuring VolitionRx Limited’s beta against major indices2025 AllTime Highs & High Accuracy Swing Trade Signals - Newser
Real time social sentiment graph for VolitionRx LimitedJuly 2025 WrapUp & AI Powered Buy/Sell Recommendations - Newser
VolitionRX (VNRX) Expected to Announce Earnings on Thursday - Defense World
How moving averages guide VolitionRx Limited tradingReal Trader Watchlist with Entry Targets - Newser
What does recent volatility data suggest for VolitionRx LimitedReversal Pattern Insights with Entry Tips - Newser
VolitionRx Limited Schedules Second Quarter 2025 Earnings Conference Call and Business Update - Yahoo Finance
What machine learning models say about VolitionRx LimitedBuy/Sell Zone Confirmation Technical Analysis - Newser
What risks could impact VolitionRx Limited stock performanceSwing Entry Insight With Forecast Accuracy - Newser
Visual analytics tools that track VolitionRx Limited performanceIntraday Strategy with Real Time Monitoring - Newser
Analyzing VolitionRx Limited with multi timeframe chartsDownside Control Plan With Support Analysis - Newser
VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering - 富途牛牛
What makes VolitionRx Limited stock price move sharplyTrade Alert System with Volume Analysis - Newser
Is it the right time to buy VolitionRx Limited stockInvest smarter with expert stock recommendations - Jammu Links News
Volatility clustering patterns for VolitionRx LimitedTrend Reversal Probability Forecast Update - Newser
What are the technical indicators suggesting about VolitionRx LimitedSkyrocketing investment returns - Jammu Links News
What are analysts’ price targets for VolitionRx Limited in the next 12 monthsGet high-impact stock recommendations now - Jammu Links News
Applying big data sentiment scoring on VolitionRx LimitedFree Investment Strategy With Predictable Gains - Newser
What is the dividend policy of VolitionRx Limited stockMarket Forecast Review For 2025 - Jammu Links News
Combining machine learning predictions for VolitionRx LimitedQuick Profit Setup with Signal Forecast - Newser
Automated trading signals detected on VolitionRx LimitedFree AI Driven Buy Alert Trade Blueprint - Newser
VolitionRx Limited Rebounds From Oversold Zone — Now WhatSwing Trading Plan With Smart Signals in Review - metal.it
Short Term Charts Align With Long Term Uptrend in VolitionRx LimitedBuy Alerts With Low Risk Confirmation Noted - beatles.ru
VolitionRX Ltd Azioni (VNRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):